Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
Sponsor: Gan and Lee Pharmaceuticals, USA
Summary
This trial is conducted in China. The aim of the trial is to compare the efficacy, tolerability, and safety of GZR101 Injection and GZR33-70 Injection in type 2 diabetes inadequately controlled on basal/ premixed insulin once daily at least with or without pre-dinner meal-time insulin.
Official title: A Phase II Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection and GZR33-70 Injection in Type 2 Diabetes Inadequately Controlled on Basal Insulin or Premixed Insulin Once Daily at Least With or Without Pre-dinner Meal-time Insulin
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-06-28
Completion Date
2024-12
Last Updated
2024-08-19
Healthy Volunteers
No
Conditions
Interventions
GZR101 Injection
Once daily
GZR33 Injection
Once daily
Insulin aspart
Once daily
Locations (1)
Study Site 01
Tianjin, China